U.S. Markets open in 5 hrs 15 mins
S&P Futures
2,440.50
-1.00 (-0.04%)Dow Futures
21,796.00
+1.00 (+0.00%)
| Previous Close | 78.26 |
| Open | 78.20 |
| Bid | 0.00 x 0 |
| Ask | 84.97 x 100 |
| Day's Range | 78.05 - 78.52 |
| 52 Week Range | 64.18 - 86.72 |
| Volume | 1,801,475 |
| Avg. Volume | 3,468,917 |
| Market Cap | 81.83B |
| Beta | 0.15 |
| PE Ratio (TTM) | 37.79 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Dividend & Yield | 2.08 (2.66%) |
| Ex-Dividend Date | 2017-08-11 |
| 1y Target Est | N/A |
- Market Realist•11 hours ago
Analysts’ Recommendations for Merck in August 2017
Of the 21 analysts tracking Merck in August 2017, three analysts recommended a “strong buy,” and ten analysts recommended a “buy.” Seven analysts recommended a "hold," and one analyst recommended ...
- Market Realist•16 hours ago
Incyte Had These Key Collaborations and Developments in 2Q17
Incyte (INCY) distributes its key drug, Jakafi, through its own network of specialty pharmacy providers and wholesalers in US markets.
- Market Realist•21 hours ago
Behind Incyte’s 2Q17 Product Portfolio
Incyte’s (INCY) product portfolio includes targeted therapies and immunotherapies for oncology as well as non-oncology products.
